C3 awarded a Travel Grant to Ruby Goldstein de Salazar, a graduate student in Dr. Melissa Spencer’s laboratory at the University of California Los Angeles. Ms. Goldstein de Salazar traveled to Hiroshima, Japan in September 2026 to present her research at the 31st annual Congress of the World Muscle Society.
Ms. Goldstein de Salazar’s presentation, titled “Design of skeletal muscle-specific promoters active in slow and fast muscle fiber types for rAAV-driven treatment of LGMD2A/R1,” showed how she engineered and tested a series of gene therapy regulatory elements to identify a candidate that restores calpain 3 expression in both slow and fast muscle fibers while minimizing calpain 3 expression in heart. A lay language explanation of the research is available below.
In recognition of her oral presentation, Ms. Goldstein de Salazar was awarded the President’s Prize for First Time Presenter.
C3 awards Travel Grants to early career investigators who are currently conducting research in the areas of calpainopathies (LGMD2A/R1 and LGMDD4) so they can present their work at relevant conferences and meetings. For more information, visit our Grant Program page.
Click on the photo below to access the full poster.

*Full author list:
Ruby Goldstein de Salazar1
Irina Kramerova1
Diana Becerra1
Bradley Smith1
Stephen Hauschka2
Jeffrey Chamberlain2
Melissa Spencer1
1Department of Neurology, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.
2Department of Neurology, University of Washington School of Medicine, Seattle, WA, USA.